Literature DB >> 12656219

Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats.

Kazumasa Ohtsuki1, Asaki Abe, Hitoshi Mitsuzuwi, Masaru Kondo, Kanae Uemura, Yumiko Iwasaki, Yasuhiro Kondo.   

Abstract

Hesperidin (HES) is a flavonoid contained in citrus fruit peel. We investigated the effects of long-term administration of HES and its newly developed water soluble analogue, glucosyl hesperidin (GHES), to spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). Animals were fed with diets containing HES or GHES (30 mg/d/kg body weight) for 25 wk. While the daily food intake and the body weight of administered rats were not different from those of the non-administered control rats in both SHR and WKY through the experimental period, the blood pressure and heart rate of SHR administered HES or GHES for longer than 15 wk decreased as compared to the control group. The blood pressure and heart rate of WKY were not changed by the long-term administration of HES or GHES. These results suggest that HES and GHES have anti-hypertensive effects on hypertensive animals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12656219     DOI: 10.3177/jnsv.48.420

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  6 in total

1.  Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.

Authors:  Stefano Rizza; Ranganath Muniyappa; Micaela Iantorno; Jeong-a Kim; Hui Chen; Philomena Pullikotil; Nicoletta Senese; Manfredi Tesauro; Davide Lauro; Carmine Cardillo; Michael J Quon
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

2.  The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Zahra Yari; Mina Movahedian; Hossein Imani; Seyed Moayed Alavian; Mehdi Hedayati; Azita Hekmatdoost
Journal:  Eur J Nutr       Date:  2019-12-16       Impact factor: 5.614

Review 3.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

4.  Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study).

Authors:  Rosa M Valls; Anna Pedret; Lorena Calderón-Pérez; Elisabet Llauradó; Laura Pla-Pagà; Judit Companys; Ana Moragas; Francisco Martín-Luján; Yolanda Ortega; Montse Giralt; Marta Romeu; Laura Rubió; Jordi Mayneris-Perxachs; Núria Canela; Francesc Puiggrós; Antoni Caimari; Josep M Del Bas; Lluís Arola; Rosa Solà
Journal:  Eur J Nutr       Date:  2020-07-13       Impact factor: 5.614

5.  Gravity-Induced Lower-Leg Swelling Can Be Ameliorated by Ingestion of α-Glucosyl Hesperidin Beverage.

Authors:  Naoki Nishimura; Satoshi Iwase; Hiroko Takumi; Keiko Yamamoto
Journal:  Front Physiol       Date:  2021-06-23       Impact factor: 4.566

Review 6.  Current Trends in the Pharmacotherapy of Cataracts.

Authors:  Segewkal H Heruye; Leonce N Maffofou Nkenyi; Neetu U Singh; Dariush Yalzadeh; Kalu K Ngele; Ya-Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.